Jaguar Health, Inc. (JAGX)
NCM · Common · CUSIP 47010C409
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for JAGX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
47010C409 (prev. 47008L106 )
Market Cap
Small Cap
IPO
$7.00/share
Previous Name
Jaguar Animal Health, Inc.
Business: Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, plant-based, sustainably derived gastrointestinal products on a global basis. Its wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Company Contact

CEO
Lisa A. Conte
CAO
Carol Lizak
Headquarters
200 Pine Street, Suite 400, San Francisco, CA 94105
Phone
415-371-8300
Investor Relations
Peter Hodge · 650-888-0902 · phodge@jaguar.health
Email Form
Request Form »
SEC EDGAR Filings
View filings »